Click Here for 5% Off Your First Aladdin Purchase!

Zansecimab (anti-ANGPT2) - Primary antibody, specific to ANGPT2, >95%, high purity, Human IgG4SP, INHIBITOR of Angiopoietin-2 inhibitor

  • Azide Free
  • Carrier Free
  • ExactAb™
  • Low Endotoxin
  • Recombinant
  • Validated
  • ≥95%(SDS-PAGE&SEC)
  • Lot by Lot
Features and benefits
  • Short Overview:

    Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

  • Species reactivity(Reacts with): Cynomolgus monkey,Dog,Human,Mouse,Rabbit,Rat
  • Isotype: Human IgG4SP
    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Item Number
Ab175707
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab175707-100μg
100μg
In stock
$59.90
Ab175707-1mg
1mg
In stock
$279.90
Ab175707-5mg
5mg
In stock
$739.90
Ab175707-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,189.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4SP; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

View related series
Accession#:O15123 ANGPT2 Gene ID:285

Basic Description

Product NameZansecimab (anti-ANGPT2) - Primary antibody, specific to ANGPT2, >95%, high purity, Human IgG4SP
SynonymsAGPT 2 antibody; Agpt2 antibody; ANG 2 antibody; ANG-2 antibody; ANG2 antibody; Angiopoietin 2a antibody; Angiopoietin 2B antibody; Angiopoietin-2 antibody; Angiopoietin2 antibody; ANGP2_HUMAN antibody; ANGPT 2 antibody; Angpt2 antibody; Tie2 ligand antib
Specifications & PurityExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
SpecificityANGPT2
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action TypeINHIBITOR
Mechanism of actionINHIBITOR of Angiopoietin-2 inhibitor
Product Description

Zansecimab (anti-ANGPT2) is an immunoglobulin G4-kappa, a monoclonal antibody against angiopoietin 2 (Ang 2). Zansecimab (anti-ANGPT2) has potential applications in angiogenesis and immune regulation.

Product Properties

IsotypeHuman IgG4SP
Light Chain Typekappa
SDS-PAGE145.24 kDa
Purification MethodProtein A purified
Purity>95%
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS2415205-37-5

Images

Zansecimab (anti-ANGPT2) (Ab175707) - SEC
The purity of Zansecimab (anti-ANGPT2) (Ab175707) is more than 95% verified by HPLC.

Zansecimab (anti-ANGPT2) (Ab175707) - ELISA
Immobilized hANGPT2-chis at 2.0 μg/mL can bind Zansecimab (anti-ANGPT2) (Ab175707) with the EC₅₀ of 14.91 ng/mL.

Associated Targets

ANGPT2 Tclin Angiopoietin-2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

3 results found

Lot NumberCertificate TypeDateItem
ZJ24F0102658Certificate of AnalysisJan 30, 2024 Ab175707
ZJ24F0102657Certificate of AnalysisJan 30, 2024 Ab175707
ZJ24F0102659Certificate of AnalysisJan 30, 2024 Ab175707

Related Documents

References

1. Regula JT, Lundh von Leithner P, Foxton R, Barathi VA, Cheung CM, Bo Tun SB, Wey YS, Iwata D, Dostalek M, Moelleken J et al..  (2016)  Targeting key angiogenic pathways with a bispecific CrossMAb optimized for neovascular eye diseases..  EMBO Mol Med,  (11): (1265-1288).  [PMID:27742718]
2. Maisonpierre, P C PC and 13 more authors..  (1997)  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis..  Science (New York, N.Y.),    (4):   [PMID:9204896]
3. Tanaka, S S and 5 more authors..  (1999)  Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma..  The Journal of clinical investigation,      [PMID:9927494]
4. Kim, I I and 5 more authors..  (2000)  Characterization and expression of a novel alternatively spliced human angiopoietin-2..  The Journal of biological chemistry,    (16):   [PMID:10766762]
5. Fiedler, Ulrike U and 8 more authors..  (2003)  Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats..  The Journal of biological chemistry,    (17):   [PMID:12427764]
6. Lee, Hyuek Jong HJ and 9 more authors..  (2004)  Biological characterization of angiopoietin-3 and angiopoietin-4..  FASEB journal : official publication of the Federation of American Societies for Experimental Biology,      [PMID:15284220]
7. Barton, William A WA, Tzvetkova, Dorothea D and Nikolov, Dimitar B DB..  (2005)  Structure of the angiopoietin-2 receptor binding domain and identification of surfaces involved in Tie2 recognition..  Structure (London, England : 1993),      [PMID:15893672]
8. Nusbaum, Chad C and 75 more authors..  (2006)  DNA sequence and analysis of human chromosome 8..  Nature,    (19):   [PMID:16421571]
9. Barton, William A WA and 6 more authors..  (2006)  Crystal structures of the Tie2 receptor ectodomain and the angiopoietin-2-Tie2 complex..  Nature structural & molecular biology,      [PMID:16732286]
10. Yacyshyn, Orisha K OK and 5 more authors..  (2009)  Tyrosine phosphatase beta regulates angiopoietin-Tie2 signaling in human endothelial cells..  Angiogenesis,      [PMID:19116766]
11. Yuan, Hai Tao HT, Khankin, Eliyahu V EV, Karumanchi, S Ananth SA and Parikh, Samir M SM..  (2009)  Angiopoietin 2 is a partial agonist/antagonist of Tie2 signaling in the endothelium..  Molecular and cellular biology,      [PMID:19223473]
12. Leppänen, Veli-Matti and 20 more authors..  (2020)  Characterization of ANGPT2 mutations associated with primary lymphedema..  Science translational medicine,    (9):   [PMID:32908006]

Solution Calculators